Aldeyra Therapeutics Reports Third-Quarter 2019 Financial Results and Provides Updates on Anticipated Clinical Milestones

Go back to Aldeyra Therapeutics Reports Third-Quarter 2019 Financial Results and Provides Updates on Anticipated Clinical Milestones
ALDEYRA THERAPEUT (NASDAQ: ALDX) Delayed: 1.37 -0.01 (0.72%)
Previous Close $1.38    52 Week High $8.19 
Open $1.40    52 Week Low $3.39 
Day High $1.40    P/E N/A 
Day Low $1.37    EPS $0.00 
Volume 115,544